株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

周波数アブレーション装置の市場:2017年〜2021年

Global Radiofrequency Ablation Market 2017-2021

発行 TechNavio (Infiniti Research Ltd.) 商品コード 323250
出版日 ページ情報 英文 70 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.53円で換算しております。
Back to Top
周波数アブレーション装置の市場:2017年〜2021年 Global Radiofrequency Ablation Market 2017-2021
出版日: 2017年04月12日 ページ情報: 英文 70 Pages
概要

世界における周波数アブレーション装置市場の2017〜2021年の年平均成長率 (CAGR) は、8.78%となることが予測されています。

当レポートでは、世界の周波数アブレーション装置市場について分析し、市場の概要や構造、市場規模の動向(今後5年間の予測値)、種類別・用途別・地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・考察しております。

第1章 エグゼクティブサマリー

第2章 調査範囲

第3章 市場調査手法

第4章 イントロダクション

第5章 市場情勢

  • 市場概要
  • ファイブフォース分析

第6章 製品別の市場区分

  • 消耗品・付属品市場
  • システム市場
  • カテーテル市場

第7章 用途別の市場区分

  • 腫瘍学
  • 心臓血管
  • 疼痛管理
  • 美容術
  • 婦人科学

第8章 エンドユーザー別の市場区分

  • 病院
  • 通院外科診療所(ASC)
  • 開業医院

第9章 地理区分

  • 南北アメリカの高周波アブレーション装置市場
  • EMEA(欧州・中東・アフリカ)地域の高周波アブレーション装置市場
  • アジア太平洋地域の高周波アブレーション装置市場

第10章 決定機構

第11章 市場成長因子と課題

第12章 市場動向

第13章 ベンダー情勢

  • 競合シナリオ

第14章 主要ベンダーの分析

  • AngioDynamics
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • Stryker
  • その他の有力ベンダー

第15章 付録

  • 略語リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR12460

About Radiofrequency Ablation

Radiofrequency ablation devices are used to treat medical conditions such as cancer tumors with the help of imaging techniques such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound by using minimally invasive (MI) techniques. This involves the use of high-frequency electromagnetic waves to generate heat energy (alternating current). Radiofrequency ablation is used by surgeons to destroy cancerous cells, and remove or trim obstructive tissues and dead nerves. The process is carried out by inserting a special needle through the skin onto the tumor. The procedure targets specific tissue/nerve with radiofrequency electrical energy, heating the tumor through an active exposed electrode tip.

Technavio's analysts forecast the global radiofrequency ablation market to grow at a CAGR of 8.78% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global radiofrequency ablation market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of equipment and accessories used in radiofrequency ablation.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Radiofrequency Ablation Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • AngioDynamics
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • Stryker

Other Prominent Vendors

  • Accuray
  • Advanced Cardiac Therapeutics
  • APT Medical
  • Arthrex
  • AtriCure
  • Biosense Webster
  • BIOTRONIK
  • Bovie Medical
  • CardioFocus
  • CONMED
  • DVx
  • Hansen Medical
  • Halyard Health
  • Imricor Medical Systems
  • Japan Lifeline
  • Merit Medical Systems
  • MicroPort Scientific
  • Osypka Medical
  • PLC Medical Systems
  • RF Medical
  • Smith & Nephew
  • Spacelabs Healthcare
  • Spectranetics
  • Theraclion
  • Total Vein Systems

Market driver

  • Increasing incidence of chronic disorders and growing older population
  • For a full, detailed list, view our report

Market challenge

  • Risks and complications associated with radiofrequency ablation
  • For a full, detailed list, view our report

Market trend

  • New product launches coupled with R&D activities
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Five forces analysis

PART 06: Market segmentation by product

  • Global radiofrequency ablation consumables and accessories market
  • Global radiofrequency ablation systems market
  • Global radiofrequency ablation catheters market

PART 07: Market segmentation by application

  • Oncology
  • Cardiovascular
  • Pain management
  • Cosmetology
  • Gynecology

PART 08: Market segmentation by end-user

  • Hospitals
  • ASCs
  • Physicians' offices

PART 09: Geographical segmentation

  • Radiofrequency ablation market in Americas
  • Radiofrequency ablation market in EMEA
  • Radiofrequency ablation market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges

  • Market drivers
  • Impact of drivers on key customer segments
  • Market challenges
  • Impact of challenges on key customer segments

PART 12: Market trends

  • New product launches coupled with R&D activities
  • Increasing M&A
  • Emergence of robotic navigation technologies
  • Adoption of radiofrequency ablation in emerging economies

PART 13: Vendor landscape

  • Competitive scenario

PART 14: Key vendor analysis

  • AngioDynamics
  • Boston Scientific
  • Medtronic
  • St. Jude Medical
  • Stryker
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global radiofrequency ablation market 2016-2021 ($ millions)
  • Exhibit 02: Five forces analysis
  • Exhibit 03: Global radiofrequency ablation market by product type 2016-2021 ($ millions)
  • Exhibit 04: Global radiofrequency ablation market by product type 2016-2021
  • Exhibit 05: Global radiofrequency ablation consumables and accessories market 2016-2021 ($ millions)
  • Exhibit 06: Global radiofrequency ablation systems market 2016-2021 ($ millions)
  • Exhibit 07: Common ablation catheters used during radiofrequency ablation procedure
  • Exhibit 08: Benefits of advanced radiofrequency ablation catheters
  • Exhibit 09: Global radiofrequency ablation catheters market 2016-2021 ($ millions)
  • Exhibit 10: Global radiofrequency ablation market by application 2016
  • Exhibit 11: Global radiofrequency ablation market by end-user 2016
  • Exhibit 12: Global radiofrequency ablation market by geography 2016-2021
  • Exhibit 13: Global radiofrequency ablation market by geography 2016: Lifecycle analysis
  • Exhibit 14: Global radiofrequency ablation market analysis by geography 2016
  • Exhibit 15: Global radiofrequency ablation market by geography 2016-2021 ($ millions)
  • Exhibit 16: Global radiofrequency ablation market by geography 2016-2021
  • Exhibit 17: Radiofrequency ablation market in Americas 2016-2021 ($ millions)
  • Exhibit 18: Radiofrequency ablation market in EMEA 2016-2021 ($ millions)
  • Exhibit 19: Radiofrequency ablation market in APAC 2016-2021 ($ millions)
  • Exhibit 20: Cancer types worldwide 2012
  • Exhibit 21: Impact of drivers
  • Exhibit 22: Product recalls in radiofrequency ablation market 2015-2016
  • Exhibit 23: Impact of challenges
  • Exhibit 24: New product launches 2015-2016
  • Exhibit 25: Ongoing clinical trials for radiofrequency ablation
  • Exhibit 26: Key M&A 2016-2017
  • Exhibit 27: Competitive structure of global radiofrequency ablation market
  • Exhibit 28: Competitive parameters in global radiofrequency ablation market
  • Exhibit 29: AngioDynamics: Strength assessment
  • Exhibit 30: AngioDynamics: Strategy assessment
  • Exhibit 31: AngioDynamics: Opportunity assessment
  • Exhibit 32: Boston Scientific: Strength assessment
  • Exhibit 33: Boston Scientific strategy assessment
  • Exhibit 34: Boston Scientific: Opportunity assessment
  • Exhibit 35: Medtronic: Strength assessment
  • Exhibit 36: Medtronic; Strategy assessment
  • Exhibit 37: Medtronic; Opportunity assessment
  • Exhibit 38: St. Jude Medical: Strength assessment
  • Exhibit 39: St. Jude Medical: Strategy assessment
  • Exhibit 40: St. Jude Medical: Opportunity assessment
  • Exhibit 41: Stryker: Strength assessment
  • Exhibit 42: Stryker: Strategy assessment
  • Exhibit 43: Stryker: Opportunity assessment
Back to Top